Customizable Cardioplegia Delivery Systems from Surge Cardiovascular
Cardioplegia solution is essential for myocardial protection during Cardiopulmonary Bypass and allows surgeons to work in a motionless field during the procedure. Regardless of the method of delivery (antegrade, retrograde, global), cardioplegia solution systems must accommodate surgeon preference and procedure types.
Surge Cardiovascular offers Cardioplegia Delivery Systems with a variety of designs that allow surgeons to create a customized circuit for their needs.
Antegrade Cardioplegia Cannulae
Surge Cardiovascular Antegrade Cardioplegia Cannulae come in a variety of options, including standard and Extended Length, 12 or 14Ga and with or without vent lines. Each version easily connects to multiple styles of perfusion sets.
Retrograde Cardioplegia Cannulae
Surge boasts more than 25 options of Retrograde Cardioplegia Cannulae to choose from, including cannulae with a smooth or textured balloon, manual or self-inflating balloons, rigid stylets or flexible guide-wires, and luer or Sure-Touch handles.
Surge’s Perfusion Sets come in nine different styles to accommodate various configurations. Combinations include vented and non-vented sets, color-coded or non-colored clamps, as well as soft or more rigid tubing and multiple lengths. Multiple coronary cannulae can be connected to a single infusion line, allowing cardioplegia solution to be delivered through either retrograde or antegrade cannulae without changing connections.
Surge offers more than ten options of Vessel Cannulae to facilitate the administration of cardioplegia solution to the heart. Vessel Cannulae come in opaque, clear and stainless steel, and are available with one-way or free-flow valves in both rigid and soft-tip styles.
MED Alliance Solutions is an ISO 13485 certified medical device distributor and has been dedicated to meeting the needs of our clinical customers and manufacturing partners since 2007. We specialize in the sales, marketing, importation, logistics and distribution of innovative, high-quality and cost-effective cardiovascular and cardiothoracic medical devices on a national basis.